PDB-code
Browse PDE entries (page 4 of 31)
First 2 PreviousLast8 7 6 Next| # | Species | PDE Type | PDB | Chain | Alternate Model | Ligand | Details | File |
|---|---|---|---|---|---|---|---|---|
 | Human | PDE10 | 4fcb | B | B | 3,4-dimethyl-1-propyl-7-(quinolin-2-ylmethoxy)imidazo[1,5-a]quinoxaline |  | |
| Human | PDE10 | 4fcd | A | A | 1-(2-chlorophenyl)-6,8-dimethoxy-3-methylimidazo[5,1-c][1,2,4]benzotriazine | | |
| Human | PDE10 | 4fcd | A | B | 1-(2-chlorophenyl)-6,8-dimethoxy-3-methylimidazo[5,1-c][1,2,4]benzotriazine | | |
| Human | PDE10 | 4fcd | B | A | 1-(2-chlorophenyl)-6,8-dimethoxy-3-methylimidazo[5,1-c][1,2,4]benzotriazine | | |
| Human | PDE10 | 4fcd | B | B | 1-(2-chlorophenyl)-6,8-dimethoxy-3-methylimidazo[5,1-c][1,2,4]benzotriazine | | |
| Human | PDE10 | 4heu | A | (1-{3-[4-(1H-benzimidazol-2-ylamino)phenoxy]pyridin-2-yl}piperidin-4-yl)methanol | | ||
| Human | PDE10 | 4heu | B | (1-{3-[4-(1H-benzimidazol-2-ylamino)phenoxy]pyridin-2-yl}piperidin-4-yl)methanol | | ||
| Human | PDE10 | 4hf4 | A | (1S)-1-(1-{3-[4-(1,3-benzothiazol-2-ylamino)phenoxy]pyrazin-2-yl}piperidin-4-yl)ethanol | | ||
| Human | PDE10 | 4hf4 | B | (1S)-1-(1-{3-[4-(1,3-benzothiazol-2-ylamino)phenoxy]pyrazin-2-yl}piperidin-4-yl)ethanol | | ||
| Human | PDE10 | 4lkq | A | A | 4-amino-1,7-dihydro-6H-pyrazolo[3,4-d]pyrimidine-6-thione | | |
| Human | PDE10 | 4lkq | A | B | 4-amino-1,7-dihydro-6H-pyrazolo[3,4-d]pyrimidine-6-thione | | |
| Human | PDE10 | 4lkq | B | A | | ||
| Human | PDE10 | 4lkq | B | B | | ||
| Human | PDE10 | 4llj | A | A | 2H-isoindole-1,3-diamine | | |
| Human | PDE10 | 4llj | A | B | 2H-isoindole-1,3-diamine | | |
| Human | PDE10 | 4llj | B | A | | ||
| Human | PDE10 | 4llj | B | B | | ||
| Human | PDE10 | 4llk | A | A | 2-methylquinazolin-4(3H)-one | | |
| Human | PDE10 | 4llk | A | B | 2-methylquinazolin-4(3H)-one | | |
| Human | PDE10 | 4llk | B | A | | ||
| Human | PDE10 | 4llk | B | B | | ||
| Human | PDE10 | 4llp | A | A | 4-amino-2-methylphenol | | |
| Human | PDE10 | 4llp | A | B | 4-amino-2-methylphenol | | |
| Human | PDE10 | 4llp | B | A | | ||
| Human | PDE10 | 4llp | B | B | | ||
| Human | PDE10 | 4llx | A | A | 4,6-dimethylpyrimidin-2-amine | | |
| Human | PDE10 | 4llx | A | B | 4,6-dimethylpyrimidin-2-amine | | |
| Human | PDE10 | 4llx | B | A | | ||
| Human | PDE10 | 4llx | B | B | | ||
| Human | PDE10 | 4lm0 | A | A | 5-NITROINDAZOLE | |
This research was performed as part of the "Phosphodiesterase inhibitors for neglected parasitic diseases" (PDE4NPD) programme, which is supported by the European Union 7th Framework Program (FP7/2007-2013) under grant agreement n° 602666.
